F2 Bioscience I 2017 Ltd - Net Worth and Insider Trading
F2 Bioscience I 2017 Ltd Net Worth
The estimated net worth of F2 Bioscience I 2017 Ltd is at least $115 Million dollars as of 2024-05-16. F2 Bioscience I 2017 Ltd is the 10% Owner of Cullinan Therapeutics Inc and owns about 4,430,964 shares of Cullinan Therapeutics Inc (CGEM) stock worth over $115 Million. Details can be seen in F2 Bioscience I 2017 Ltd's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that F2 Bioscience I 2017 Ltd has not made any transactions after 2022-06-23 and currently still holds the listed stock(s).
Transaction Summary of F2 Bioscience I 2017 Ltd
F2 Bioscience I 2017 Ltd Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, F2 Bioscience I 2017 Ltd owns 1 companies in total, including Cullinan Therapeutics Inc (CGEM) .
Click here to see the complete history of F2 Bioscience I 2017 Ltd’s form 4 insider trades.
Insider Ownership Summary of F2 Bioscience I 2017 Ltd
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CGEM | Cullinan Therapeutics Inc | 2022-06-23 | 10 percent owner |
F2 Bioscience I 2017 Ltd Latest Holdings Summary
F2 Bioscience I 2017 Ltd currently owns a total of 1 stock. F2 Bioscience I 2017 Ltd owns 4,430,964 shares of Cullinan Therapeutics Inc (CGEM) as of June 23, 2022, with a value of $115 Million.
Latest Holdings of F2 Bioscience I 2017 Ltd
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CGEM | Cullinan Therapeutics Inc | 2022-06-23 | 4,430,964 | 26.01 | 115,249,374 |
Holding Weightings of F2 Bioscience I 2017 Ltd
F2 Bioscience I 2017 Ltd Form 4 Trading Tracker
According to the SEC Form 4 filings, F2 Bioscience I 2017 Ltd has made a total of 1 transactions in Cullinan Therapeutics Inc (CGEM) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Cullinan Therapeutics Inc is the sale of 101,903 shares on June 23, 2022, which brought F2 Bioscience I 2017 Ltd around $1 Million.
Insider Trading History of F2 Bioscience I 2017 Ltd
- 1
F2 Bioscience I 2017 Ltd Trading Performance
F2 Bioscience I 2017 Ltd Ownership Network
F2 Bioscience I 2017 Ltd Owned Company Details
What does Cullinan Therapeutics Inc do?
Who are the key executives at Cullinan Therapeutics Inc?
F2 Bioscience I 2017 Ltd is the 10 percent owner of Cullinan Therapeutics Inc. Other key executives at Cullinan Therapeutics Inc include See Remarks Jennifer Michaelson , Acting Chief Business Officer Savill Corrine , and director & President and CEO Nadim Ahmed .
Cullinan Therapeutics Inc (CGEM) Insider Trades Summary
Over the past 18 months, F2 Bioscience I 2017 Ltd made no insider transaction in Cullinan Therapeutics Inc (CGEM). Other recent insider transactions involving Cullinan Therapeutics Inc (CGEM) include a net sale of 83,555 shares made by Jennifer Michaelson , a net sale of 6,823 shares made by Jeffrey Trigilio , and a net sale of 3,809 shares made by Jeffrey Alan Jones .
In summary, during the past 3 months, insiders sold 63,606 shares of Cullinan Therapeutics Inc (CGEM) in total and bought 0 shares, with a net sale of 63,606 shares. During the past 18 months, 224,214 shares of Cullinan Therapeutics Inc (CGEM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 224,214 shares.
Cullinan Therapeutics Inc (CGEM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cullinan Therapeutics Inc Insider Transactions
F2 Bioscience I 2017 Ltd Mailing Address
Above is the net worth, insider trading, and ownership report for F2 Bioscience I 2017 Ltd. You might contact F2 Bioscience I 2017 Ltd via mailing address: 8, Rue Saint-leger, Geneva V8 Ch 1205.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
